| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $19.93B | $17.44B | $13.63B |
| YoY Revenue Growth % | +14.3% | +27.9% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $5.19B | $5.09B | $5.24B |
| Operating Margin % | 26.0% | 29.2% | 38.5% |
| Net Income (GAAP) | $4.40B | $4.31B | $4.44B |
| EBITDA (Normalized) | $5.91B | $5.72B | $5.73B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $6.17B | $6.67B | $5.75B |
| Capital Expenditures (CapEx) | $896.8M | $784.8M | $613.5M |
| Free Cash Flow (FCF) | $5.28B | $5.89B | $5.14B |
| FCF Margin % | 26.5% | 33.8% | 37.7% |
| Return on Invested Capital (ROIC %) | 8.5% | 9.5% | 35.2% |
| Cash & Short-Term Equivalents | $993.0M | $979.0M | — |
| Total Debt (Short + Long Term) | $24.77B | $22.54B | $4.56B |
| Total Stockholders' Equity | $24.21B | $20.82B | $9.36B |